ALS C9ORF72

This topic has 4 replies, 2 voices, and was last updated 1 year ago by Jörg Dimmeler.

Viewing 4 reply threads

Author

Posts
- November 8, 2021 at 6:27 am #20948
  
  Jörg Dimmeler
  Participant
  
  It is a fact that the C9ORF72 study was rejected by the ethics commission in Germany. Am I doomed There is nothing that can help me. ?????
- November 8, 2021 at 6:34 am #20949
  
  Jean-Pierre Le Rouzic
  Participant
  
  > C9ORF72 study was rejected by the ethics commission in Germany.
  Which study?
  Do you have a link or a clinical trial number?
  
  Otherwise my feeling is that a quiet life, without drugs/alcohol/intense sports with good organic food and a good diet (pALS need much more energy while they are still able to move), is probably something which makes sense.
- November 8, 2021 at 10:51 am #20952
  
  Jörg Dimmeler
  Participant
  
  The study should have taken place in the University Clinic Tübingen on behalf of the company Wave
- November 8, 2021 at 10:58 am #20953
  
  Jörg Dimmeler
  Participant
  
  https://ir.wavelifesciences.com/news-releases/news-release-details/wave-life-sciences-announces-initiation-dosing-phase-1b2a-focus
  - November 9, 2021 at 1:42 am #20965
    
    Jean-Pierre Le Rouzic
    Participant
    
    > This link tells that a new clinical trial is starting, it does not tell it is stopped?
- November 9, 2021 at 2:44 am #20966
  
  Jörg Dimmeler
  Participant
  
  The responsible ethics committee has again not approved the study at the current point in time, despite the previous detailed objection letter. The main point here is the argument of the responsible ethics committee that placebo control of the study is not permitted.
Author

Posts